General Information
Revision date
2021-04-26
Product name
Carmustine powder and solvent for injection, 100 mg/vial
CAS No.
154-93-8
1.2.1 Relevant identified uses
Multiple Myeloma / Plasma Cell Disorders
Manufacturer Name
Sponsor
Icons in SDS
Company Information
company name
Accord Healthcare Pty Ltd
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H300, H350, H360
Hazard statements
Code
Statements
H300
Fatal if swallowed
H350
May cause cancer
H360
May damage fertility or the unborn child
Section 2
SECTION 2: Hazards identification
Principal Hazards of the : H300: Fatal if swallowed. product H350: May cause cancer. H360: May damage fertility or the unborn child. Harmful Effect of the drug on Fatal if swallowed. Health Effects on the Environment : The environmental impact of this product has not been fully investigated.
Other physicochemical hazards
Fatal if swallowed May cause genetic defects May cause cancer May damage fertility or the unborn child
Potential chronic health
Investigated as a drug, mutagen, reproductive effector, Effects and tumorigenic. Carcinogenic Effects : Not available. Mutagenic Effects : Not available.
Teratogenic Effects
Not available. Developmental Toxicity : Not available. Material may be irritating to the mucous membranes and upper respiratory tract. May be harmful by inhalation or skin absorption. May cause cancer. May cause eye, skin, or respiratory system irritation. May damage fertility or the unborn child. To the best of our knowledge, the toxicological properties have not been thoroughly investigated.